Last reviewed · How we verify
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 is a Biologic drug developed by GeoVax, Inc.. It is currently in Phase 2 development. Also known as: COH04S1, SARS-CoV-2 Vaccine COH04S1, sMVA-based SARS-CoV-2 Vaccine COH04S1, GEO-CM04S1.
At a glance
| Generic name | Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 |
|---|---|
| Also known as | COH04S1, SARS-CoV-2 Vaccine COH04S1, sMVA-based SARS-CoV-2 Vaccine COH04S1, GEO-CM04S1 |
| Sponsor | GeoVax, Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia (PHASE2)
- SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer (PHASE2)
- A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 CI brief — competitive landscape report
- Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 updates RSS · CI watch RSS
- GeoVax, Inc. portfolio CI
Frequently asked questions about Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
What is Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1?
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 is a Biologic drug developed by GeoVax, Inc..
Who makes Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1?
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 is developed by GeoVax, Inc. (see full GeoVax, Inc. pipeline at /company/geovax-inc).
Is Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 also known as anything else?
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 is also known as COH04S1, SARS-CoV-2 Vaccine COH04S1, sMVA-based SARS-CoV-2 Vaccine COH04S1, GEO-CM04S1.
What development phase is Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 in?
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 is in Phase 2.
Related
- Manufacturer: GeoVax, Inc. — full pipeline
- Also known as: COH04S1, SARS-CoV-2 Vaccine COH04S1, sMVA-based SARS-CoV-2 Vaccine COH04S1, GEO-CM04S1
- Compare: Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 vs similar drugs
- Pricing: Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 cost, discount & access